Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces today its latest innovation, the CochlearTM Nucleus® 7 Sound Processor. Approved by the U.S. Food and Drug Administration (FDA) in June, the Nucleus 7 Sound Processor is the world’s first Made for iPhone cochlear implant sound processor and the smallest and lightest behind-the-ear cochlear implant sound processor available on the market.1-3
Cochlear Limitedが発表した「Cochlear™Nucleus®7 Sound Processor」は、FDA(米国食品医薬品局)から承認された、世界で初めてMade for iPhoneの蝸牛インプラントで、従来のものと比べて25%小さく、24%軽く、バッテリー寿命が50%延びています。
There are 360 million people living with disabling hearing loss worldwide, and this figure is set to more than triple to 1.2 billion by 2050.6,7 According to the World Health Organization, there are approximately 72 million people who could potentially benefit from the use of a hearing device including a cochlear implant or hearing aid.8